Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer. od Dudderidge, T, McCracken, SR, Loddo, M, Fanshawe, T, Kelly, J, Neal, D, Leung, H, Williams, G, Stoeber, K

FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth. od Brooke, G, Culley, R, Dart, D, Mann, D, Gaughan, L, McCracken, SR, Robson, C, Spencer-Dene, B, Gamble, S, Powell, S, Wait, R, Waxman, J, Walker, M, Bevan, C

IKBKE activity enhances AR levels in advanced prostate cancer via modulation of the Hippo pathway od Bainbridge, A, Walker, S, Smith, J, Patterson, K, Dutt, A, Ng, YM, Thomas, HD, Wilson, L, McCullough, B, Jones, D, Maan, A, Banks, P, McCracken, SR, Gaughan, L, Robson, CN, Coffey, K